Full name
DAR-FARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0,2 | -0 | -113,1 |
Gross profit (loss) | 0,1 | 0,2 | -0,1 | -164,4 |
EBITDA | 0,1 | 0,1 | -0,1 | -172,2 |
Short time liabilities | 2,5 | 2,5 | 2,8 | 13 |
Other operating costs | 0,1 | 0,1 | 0,1 | 11,4 |
Equity capital | 3,4 | 3,6 | 3,5 | -4,2 |
Operating profit (EBIT) | 0,1 | 0,1 | -0,1 | -219,5 |
Assets | 6 | 6,3 | 6,5 | 2,7 |
Net profit (loss) | 0,1 | 0,2 | -0,2 | -170 |
Cash | 0 | 0 | 0 | 20,1 |
Net income from sale | 12,8 | 13,7 | 15 | 9,6 |
Liabilities and provisions for liabilities | 2,6 | 2,7 | 3 | 12,2 |
Working assets | 3,1 | 3,3 | 3,5 | 7,1 |
Other income costs | 0 | 0 | 0 | -64,9 |
Depreciation | 0 | 0 | 0 | 22,2 |
% | % | % | p.p. | |
Profitability of capital | 1,9 | 6 | -4,4 | -10,4 |
Equity capital to total assets | 56,9 | 57,8 | 53,9 | -3,9 |
Gross profit margin | 0,5 | 1,3 | -0,8 | -2,1 |
EBITDA Margin | 0,6 | 1,1 | -0,7 | -1,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 72 | 67 | 69 | 2 |
Current financial liquidity indicator | 1.2045787572860718 | 1.3051211833953857 | 1.2375482320785522 | -0,1 |
Net dept to EBITDA | -0.2914736866950989 | -0.1570064127445221 | 0.2611323893070221 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane